EU Has Moved Sputnik V Approval Process to a Purely Political Plane
It's not looking at vaccine's efficacy and safety, but whether Russia's testing process was sufficiently ethical
In my essays of the past month dealing with Covid, I pointed to the EU’s going slow in approving the Russian Sputnik V vaccine for use in Europe. I said there was “no way in hell” that von der Leyen would allow its approval.
The justice of my analysis was supported this past week by the announcement of a new dimension to the approvals process of Sputnik V: one that violates directly the maxim of our day to “follow the science” and shifts the approval process to a purely political plane. I refer to an article in The Financial Times of 7 April entitled “EU regulator to probe ethical standards of Sputnik vaccine trials.”
The European Medicines Agency will now examine whether Sputnik V trials met ‘good clinical practice’ – not in its technical dimension but in its ‘ethical’ dimension. In particular, the EMA is questioning whether military servicemen and state employees who took part in trials did so under pressure from their superiors. It is crystal clear that the intention of EU regulators is to disqualify Sputnik V on the basis of spurious denunciations that have been solicited for this purpose.
All of these machinations come at a particularly interesting moment when Europe, already far short of vaccines to raise the general level of vaccinated population to herd immunity by autumn, has just suffered another blow to its ambitions by the revelations of rare and deadly blood clots associated with administration of the Astra Zeneca and Johnson & Johnson vaccines, compelling authorities to limit their use to specific age bands.
Source: Gilbert Doctorow